Bank of New York Mellon’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
Other funds holding TENX
N
PAM
LCM
Bank of New York Mellon's TENX Position: Q2 2026 in Review
Bank of New York Mellon opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 325,296 shares worth $4.73M. The stake represents ﹤0.01% of the portfolio and ranks #2469 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in TENX as recently as Q1 2020.
Bank of New York Mellon first reported a position in TENX in Q1 2014 and has held it in 23 quarters since. 33 funds tracked by Wall St. Rank hold TENX as of Q2 2026.
- Bank of New York Mellon held 325,296 shares of Tenax Therapeutics worth $4.73M as of Q2 2026.
- Tenax Therapeutics was a new Bank of New York Mellon position in Q2 2026.
- Tenax Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2469 holding.
- Bank of New York Mellon first reported a position in Tenax Therapeutics in Q1 2014 and has held it in 23 quarters since.
- 33 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.